Kratom and antidepressants: the serotonin syndrome risk nobody mentions
Kratom is most often discussed as an opioid-acting substance, and that framing is accurate as far as it goes. What gets less attention is that kratom's alkaloids also interact with serotonin pathways. That second layer of activity is why combining kratom with antidepressants is riskier than most people realize, and why published case reports describe a specific, serious interaction.
The risk is serotonin syndrome: a toxic state caused by too much serotonergic activity in the nervous system. It ranges from uncomfortable to life-threatening depending on severity, and it can appear quickly after combining or increasing serotonergic substances.
This page explains the mechanism, what the clinical evidence shows, what symptoms to watch for, and what to do.
At a glance: kratom and antidepressants
Key Takeaways
- Kratom is not only an opioid. Its alkaloids also interact with serotonin receptors, which makes it more pharmacologically active alongside antidepressants than most people expect.
- There is a dual mechanism. Kratom adds its own serotonergic activity and inhibits the liver enzymes that metabolize many antidepressants, which can push antidepressant levels higher than intended.
- Published case reports document the risk. Serotonin syndrome has been reported in patients combining kratom with prescribed serotonergic medications, including SSRIs and other psychotropic drugs.
- The evidence is mostly case reports, often involving other substances. This is a real caution, not a guarantee of harm, and the risk appears higher when multiple serotonergic agents are involved simultaneously.
- Do not stop your antidepressant. Kratom is the problematic addition. Abrupt antidepressant discontinuation carries its own serious risks. Talk to your prescriber.
Why kratom affects serotonin
Kratom is primarily known as an opioid-receptor-acting substance, and that is accurate. But it is not the complete picture. Kratom's alkaloids also interact with serotonin (5-HT) receptors and norepinephrine pathways, which is partly why kratom at lower doses produces a stimulant, mood-lifting effect rather than pure opioid sedation.
A published pharmacology case report (Brogdon et al., Journal of Addiction Medicine, 2022) documented the CYP enzyme inhibition dimension of this interaction: kratom alkaloids inhibit multiple cytochrome P450 liver enzymes, particularly CYP2D6 and CYP3A4. These are the same enzymes that metabolize many common antidepressants, including paroxetine (Paxil), fluoxetine (Prozac), sertraline (Zoloft), venlafaxine (Effexor), and others.
When CYP2D6 and CYP3A4 are inhibited, the antidepressant is cleared more slowly from the bloodstream. The result is that a person taking a stable antidepressant dose may accumulate higher drug levels than intended when kratom is added, because the body's mechanism for clearing the antidepressant is impaired.
Combined with kratom's own serotonergic activity, this creates two simultaneous pathways toward elevated serotonin signaling in the nervous system:
What serotonin syndrome looks like
Serotonin syndrome occurs when serotonin activity in the nervous system becomes excessive. Clinically, it is characterized by a triad of symptom clusters, assessed using the Hunter Serotonin Toxicity Criteria, the standard diagnostic framework:
Neuromuscular signs (often the earliest and most diagnostic):
- Tremor
- Muscle twitching (myoclonus)
- Exaggerated deep tendon reflexes (hyperreflexia)
- Muscle rigidity, particularly in severe cases
- Incoordination
Autonomic signs:
- Rapid heart rate (tachycardia)
- Elevated blood pressure
- Sweating (diaphoresis)
- Fever (hyperthermia)
- Dilated pupils
Mental status changes:
- Agitation
- Anxiety
- Confusion
- Disorientation
The syndrome exists on a spectrum. Mild presentations may feel like a flu with tremor and anxiety. Severe presentations, with very high fever, severe rigidity, and confusion, are a medical emergency and can be life-threatening.
Timing: serotonin syndrome typically develops quickly, often within hours of combining or increasing a serotonergic substance. Tremor and muscle twitching tend to appear first.
What the published evidence shows
Three published case reports document kratom-associated serotonin syndrome:
Zweifel, Browne, and Levine (Medical Science and Discovery, 2021) described a patient who presented to a psychiatric hospital with a mixed toxic syndrome involving chronic kratom use, a prescribed SSRI, and acute methamphetamine ingestion. The patient had psychosis, tremor, myoclonus, and extreme anxiety, consistent with serotonin syndrome and opioid withdrawal.
Eudaley, Brooks, and Hamilton (Journal of Pharmacy Practice, published 2022, printed 2023) reported a 63-year-old male who presented with sweating, flushing, aphasia, confusion, right facial droop, temperature of 39.6°C, and elevated creatine phosphokinase while taking kratom alongside multiple prescribed psychotropic medications. The case was assessed as possible serotonin syndrome, with the authors concluding that kratom's CYP enzyme inhibition raised the serotonergic drug levels and contributed to the presentation.
Saber et al. (Critical Care Medicine, 2024) presented a case study of serotonin syndrome due to kratom and antidepressant interaction at a critical care conference, further documenting the clinical concern.
The honest evidence framing: these are case reports, and in at least two of the three cases, multiple serotonergic or psychoactive substances were present simultaneously. This means the contribution of kratom specifically is difficult to isolate. The risk appears real and the mechanism is biologically plausible, but it is not a guarantee of harm from every kratom-plus-antidepressant combination. The risk increases when multiple serotonergic agents are stacked together.
Which combinations are riskiest
Antidepressant classes with serotonergic activity:
- SSRIs: sertraline, fluoxetine, paroxetine, escitalopram, citalopram, fluvoxamine
- SNRIs: venlafaxine, duloxetine, desvenlafaxine
- MAOIs: phenelzine, tranylcypromine, selegiline (generally considered the highest-risk serotonergic class)
- TCAs: amitriptyline, nortriptyline, clomipramine
- Other: buspirone, mirtazapine
Other serotonergic medications that compound the risk:
- Tramadol and tapentadol (opioid pain medications with serotonergic activity, often not recognized as such)
- Triptans (used for migraines)
- Certain anti-nausea medications
- Lithium
- St. John's Wort
The more serotonergic agents present simultaneously, the higher the risk. This is why the published case reports involve polysubstance situations: the threshold for serotonin syndrome is more easily crossed when multiple agents are contributing to elevated serotonergic tone.
What to do and what not to do
Do not stop your antidepressant
This is the most important message for anyone reading this who takes a prescribed antidepressant. Stopping an antidepressant abruptly carries its own serious risks, including discontinuation syndrome, rebound depression, and in some cases increased psychiatric symptoms. The antidepressant is not the problem. Kratom is the addition that creates the interaction risk.
Tell your prescriber
If you are using kratom and taking any antidepressant or other serotonergic medication, your prescriber needs to know. This is not about judgment; it is about accurate information for medication management. CYP enzyme inhibition affects drug levels, and your prescriber cannot account for that interaction without knowing kratom is in the picture.
Get emergency care for severe symptoms
If you or someone you are with develops:
- High fever with rapid heart rate and muscle rigidity
- Confusion or disorientation alongside physical symptoms
- Severe muscle twitching or inability to stand
Call 911 or go to the emergency department immediately. Severe serotonin syndrome is a medical emergency.
If kratom has become hard to stop
Many people using kratom alongside antidepressants started because they were looking for mood support and found kratom had an effect. If stopping has become difficult, that is a sign of physical dependence that is treatable. Buprenorphine/naloxone is the evidence-based treatment for kratom and 7-OH dependence and is accessible through telehealth in most states. Learn how Bicycle Health's treatment works.
Frequently Asked Questions
Can you take kratom with antidepressants?
There is a documented pharmacological interaction risk. Kratom inhibits liver enzymes that clear many antidepressants and adds its own serotonergic activity, which can raise serotonin signaling above what either substance would do alone. Published case reports describe serotonin syndrome in patients using kratom alongside prescribed serotonergic medications. Whether any individual combination causes harm depends on the specific medications, doses, and individual factors, which is why the appropriate response is to tell your prescriber about kratom use rather than trying to assess the risk independently.
What does kratom serotonin syndrome feel like?
Early signs typically include tremor, muscle twitching, increased heart rate, and agitation. Moderate cases add elevated temperature, sweating, and confusion. Severe cases involve very high fever, significant muscle rigidity, and marked confusion or agitation. Symptoms tend to develop within hours of a change in serotonergic drug exposure. The Hunter Serotonin Toxicity Criteria is the standard clinical tool for diagnosis.
Which antidepressants are most risky to combine with kratom?
All antidepressant classes with serotonergic activity carry some degree of interaction risk when combined with kratom's CYP enzyme inhibition and serotonergic activity. MAOIs carry the highest general risk. SSRIs and SNRIs are the most commonly prescribed antidepressants and are metabolized through the CYP enzymes that kratom inhibits. Tramadol, which is often used as a pain medication rather than classified as an antidepressant, also has serotonergic activity and adds to the risk.
Is serotonin syndrome from kratom serious?
It ranges from uncomfortable to life-threatening depending on severity. Mild cases are unpleasant but manageable. Severe cases with high fever, rigidity, and altered consciousness are medical emergencies. Anyone experiencing moderate or severe symptoms should seek medical care promptly. Do not wait to see whether symptoms resolve on their own if fever and muscle rigidity are present together.
Should I stop my antidepressant if I am using kratom?
No. Do not stop a prescribed antidepressant without your prescriber's guidance. Abrupt discontinuation carries real risks. If you are concerned about the interaction, the appropriate step is to speak with your prescriber about your kratom use. They can advise on whether any changes to your medication regimen are appropriate.
Sources
- Eudaley ST, Brooks SP, Hamilton LA. Case report: possible serotonin syndrome in a patient taking kratom and multiple serotonergic agents. Journal of Pharmacy Practice. 2023;36(6):1523-1527. doi:10.1177/08971900221116009. PMID: 35840540. https://pubmed.ncbi.nlm.nih.gov/35840540/
- Zweifel HR, Browne J, Levine JM. A case of a mixed overdose involving kratom (Mitragyna speciosa) leading to serotonin syndrome. Medical Science and Discovery. 2021;8(12):735-737. https://medscidiscovery.com/index.php/msd/article/view/626
- Saber M, et al. Serotonin syndrome due to kratom and antidepressant interaction: a case study. Critical Care Medicine. 2024;52(1):S642. doi:10.1097/01.ccm.0001003528.44177.18. https://journals.lww.com/ccmjournal/fulltext/2024/01001/1342__serotonin_syndrome_due_to_kratom_and.1286.aspx
- Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A case of potential pharmacokinetic kratom-drug interactions resulting in toxicity and subsequent treatment of kratom use disorder with buprenorphine/naloxone. Journal of Addiction Medicine. 2022. doi:10.1097/ADM.0000000000001032.
- Alsbrook S, Pro G, Koturbash I. From kratom to 7-hydroxymitragynine: evolution of a natural remedy into a public-health threat. Pharmaceutical Biology. 2025;63:896-911. doi:10.1080/13880209.2025.2590311. https://www.tandfonline.com/doi/full/10.1080/13880209.2025.2590311
- Boyer EW, Shannon M. The serotonin syndrome. New England Journal of Medicine. 2005;352(11):1112-1120. doi:10.1056/NEJMra041867.
- Dunkley EJC, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(9):635-642. doi:10.1093/qjmed/hcg109.
- U.S. Food and Drug Administration. FDA and Kratom. FDA; updated February 2026. https://www.fda.gov/news-events/public-health-focus/fda-and-kratom
- Barrett E, Hendy L, Lira MC, et al. What Clinicians Should Know About Kratom and 7-OH Mitragynine. AIM Clinical Cases (Annals of Internal Medicine: Clinical Cases). 2026;5:e251249. doi:10.7326/aimcc.2025.1249. https://www.acpjournals.org/doi/10.7326/aimcc.2025.1249
- National Institute on Drug Abuse. Medications for Opioid Use Disorder. NIDA. Updated May 2025. https://nida.nih.gov/research-topics/medications-opioid-use-disorder